Ketamine Assisted Psychotherapy
PTSD Treatment
While trauma happened in the past, it continues to live for many in the nervous system, shaping relationships, sleep, emotions, self-worth, and the ability to feel safe, valued, and rooted in the world.
Post-Traumatic Stress Disorder (PTSD) can emerge after overwhelming experiences such as childhood neglect, abuse, accidents, combat exposure, medical trauma, loss, addiction, betrayal, or prolonged stress. Sometimes the effects are obvious. Other times they appear quietly through anxiety, emotional numbness, hypervigilance, panic, irritability, disconnection, or difficulty trusting yourself and others.
Many of the people who come through our doors at Siskiyou Counseling are intelligent, capable, and deeply resilient. They have often spent years trying to “push through,” only to discover that trauma is not something to be reasoned away. Healing requires safety, attunement, and approaches that help the brain and body finally recognize that the danger has passed.
Trauma-Informed Therapy Rooted in Neuroscience and Compassion
Our work continues to evolve. It is grounded in current understandings of trauma, interpersonal neurobiology, and the nervous system. We draw from approaches like Brainspotting, EMDR, somatic awareness, mindfulness-based practices, and relational psychotherapy to help clients process unresolved experiences at a pace that feels manageable and respectful.
Rather than asking you to endlessly retell painful stories, we strive to create conditions where the mind and body can begin releasing patterns of fear, protection, and survival that may no longer serve you.
Ketamine-Assisted Psychotherapy (KAP) for PTSD
For some individuals living with PTSD or complex trauma, traditional therapy alone may not create enough movement. In these situations, Ketamine-Assisted Psychotherapy (KAP) may offer another path forward.
KAP at our Siskiyou Counseling offices combines carefully supervised ketamine treatment with psychotherapy in a collaborative and highly intentional process. Research suggests ketamine may temporarily increase neuroplasticity and reduce rigid patterns of fear and emotional reactivity, paving the way for valuable and previously unavailable windows of opportunity to do deeper therapeutic work and emotional processing.
At Siskiyou Counseling, KAP will not be approached as a quick fix or standalone intervention. Integration and making meaning of experience is everything. KAP is integrated into a broader therapeutic relationship with an emphasis on thoughtful preparation, safety, and artfully making meaning with you – integrating this into your life. Medicine alone is not the treatment. Healing emerges through the relationship between experience, the nervous system, and the therapeutic process.
Through our unique and collaborative-care-relationship with Journey Clinical, eligible clients may receive medical evaluation, prescribing support, and ongoing psychiatric oversight as part of a carefully coordinated treatment plan. Journey Clinical is the largest psychedelic-assisted psychotherapy platform in the United States, with a network of 3,000 licensed psychotherapists across approximately 30 states. Journey Clinical describes this model as combining psychotherapy, medical screening, preparation sessions, monitored dosing experiences, and integration work to support lasting change.
Some clients report that KAP helps them:
Feel less emotionally trapped by traumatic memories
Experience greater emotional flexibility and openness
Reduce hypervigilance and chronic activation
Access emotions that previously felt unreachable
Re-engage with relationships, purpose, and daily life
Deepen the effectiveness of ongoing therapy work
KAP is not appropriate for everyone, and careful screening is essential. We are committed to approaching this work ethically, thoughtfully, and with respect for both the potential benefits and limitations of psychedelic-assisted psychotherapy.
KAP at Siskiyou Counseling: A Therapeutic Relationship built on Integrity
Many trauma survivors have spent years feeling unseen, misunderstood, or pathologized. We continue to strive to create an environment that not only feels grounded and collaborative, but also one that is built upon solid ethical principles.
We are aware how Ketamine has captured the attention of the media. These are early days for established above-ground clinical Psychedelic treatment. While the people at M.A.P.S., have worked since its inception as a non-profit in 1986 to guide the evolution of research-supported integration of psychedelic studies, we have taken our time in getting involved. We are ready to work with select clients on a limited basis in the office.
KAP Resources
Pollan,M. (2018). How to change your mind: What the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence.
Begin the Conversation
If you are struggling with the effects of trauma and are curious about Ketamine-Assisted Psychotherapy, we welcome your inquiry.
You do not need to have everything figured out before making contact.
Other Relevant Resources
Dana, D. (2021). Anchored: How to befriend your nervous system using Polyvagal Theory. Sounds True.
Goldstein, J., & Kornfield, J. (1987). Seeking the heart of wisdom: The path of insight meditation. Shambala Publications.
Kabat-Zinn, J. (2013). Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness (Rev. ed.). Bantam Books.
Kornfield, J. (2009). A path with heart: A guide through the perils and promises of spiritual life. Bantam Books.
Levine, P. and Frederick, A. (1997). Waking the tiger: Healing Trauma. North Atlantic Books.
Mate, G. (2011). When the body says no: Understanding the stress-disease connection. Random House.
Porges, S. The polyvagal theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation. Norton.
13 recent peer reviewed research articles focused on Ketamine Assisted Psychotherapy
1. Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs, 51(2), 189–198. https://doi.org/10.1080/02791072.2019.1587556
2. Halstead, M., Reed, S., Krause, R., & Williams, M. T. (2021). Ketamine-assisted psychotherapy for PTSD related to racial discrimination. Clinical Case Studies, 20(4), 310–330. https://doi.org/10.1177/1534650121990894
3. Yermus, R., Bottos, J., Bryson, N., De Leo, J. A., Earleywine, M., Hackenburg, E., Kennedy, S., Kezemidis, M., Kratina, S., McMaster, R., Medrano, B., Mina, M., Morisano, D., Muench, M., Pillai, S., Scharlach, R., Setlur, V., Verbora, M., Wolfson, E., Zaer, N., & Lo, C. (2024). Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety, and post-traumatic stress disorder at 3 and 6 months: Findings from a large retrospective effectiveness study. Psychedelic Medicine, 2(2), 87–95. https://doi.org/10.1089/psymed.2023.0021
4. Duek, O., Korem, N., Li, Y., Kelmendi, B., Amen, S., Gordon, C., Milne, M., Krystal, J. H., & Levy, I. (2023). Long-term structural and functional neural changes following a single infusion of ketamine in PTSD. Neuropsychopharmacology, 48, 1484–1492. https://doi.org/10.1038/s41386-023-01606-3
5. Mathai, D. S., Meyer, M. J., Storch, E. A., & Kosten, T. R. (2020). The emerging role of ketamine-assisted psychotherapy in mental health treatment: A systematic review. Frontiers in Psychiatry, 11, 597512. https://doi.org/10.3389/fpsyt.2020.597512
6. Wheeler, S. W., & Dyer, N. L. (2020). A systematic review of ketamine-assisted psychotherapy in the treatment of alcohol use disorder and treatment-resistant depression. Journal of Psychoactive Drugs, 52(5), 418–429. https://doi.org/10.1080/02791072.2020.1760188
7. Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018). The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. American Journal of Psychiatry, 175(2), 150–158. https://doi.org/10.1176/appi.ajp.2017.17040472
8. Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J. W., Pietrzak, R. H., Murrough, J. W., Charney, D. S., & Krystal, J. H. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193–202. https://doi.org/10.1176/appi.ajp.2020.20050596
9. Ragnhildstveit, A., Slayton, M., & McIntyre, R. S. (2022). Ketamine-assisted psychotherapy: A systematic narrative review of the literature. Journal of Affective Disorders, 315, 64–77. https://doi.org/10.1016/j.jad.2022.07.030
10. Bahji, A., Vazquez, G. H., & Zarate, C. A. (2021). Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. Journal of Affective Disorders, 278, 542–555. https://doi.org/10.1016/j.jad.2020.09.071
11. Daws, R. E., Timmermann, C., Giribaldi, B., Sexton, J. D., Wall, M. B., Erritzoe, D., Roseman, L., Nutt, D., & Carhart-Harris, R. (2022). Increased global integration in the brain after psilocybin therapy for depression. Nature Medicine, 28, 844–851. https://doi.org/10.1038/s41591-022-01744-z
12. Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., & McDonald, W. M. (2020). Psychedelics and psychedelic-assisted psychotherapy. American Journal of Psychiatry, 177(5), 391–410. https://doi.org/10.1176/appi.ajp.2019.19010035
13. Drozdz, S. J., Goel, A., McGowan, S. K., et al. (2022). Ketamine-assisted psychotherapy: A systematic review of the literature and future directions. Harvard Review of Psychiatry, 30(1), 8–26. https://doi.org/10.1097/HRP.0000000000000325